Idiopathic granulomatous mastitis. Granulomatous disorder of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Patients who did not respond well to prednisolone (20 to 30 mg) treated with cinnora (Cinnagen Company) 40 mg every two weeks subcutaneously with prednisolone in th
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with granulomatous mastitis in breast mass pathology in whom the known causes of granulomatous mastitis have been ruled out Resistance to prednisolone treatment with a dose of 20 to 30 for 3 months Hepatitis B, hepatitis C and TB negative
Exclusion criteria
Exclusion criteria: Patients with infectious mastitis or positive bacterial culture Patients with granulomatous mastitis with caseous necrosis Patients with culture or PCR positive for TB People with breast cancer Patients with hepatitis B or hepatitis C positive
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response to treatment. Timepoint: monthly. Method of measurement: Lack of response is considered if the clinical and paraclinical symptoms improve by less than 25% , in case of improvement 25 to 75% relative response and in case of improvement above 75%, the answer is considered complete. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMona Ziaei
Kashan University of Medical Sciences
Outcome results
None listed